SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000921895-16-004953
Filing Date
2016-06-16
Accepted
2016-06-16 09:21:36
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO THE SCHEDULE 13D sc13da110623002_06142016.htm SC 13D/A 79563
  Complete submission text file 0000921895-16-004953.txt   81009
Mailing Address 2091 STIERLIN COURT MOUNTAIN VIEW CA 94043
Business Address 2091 STIERLIN COURT MOUNTAIN VIEW CA 94043 650.944.7000
Alexza Pharmaceuticals Inc. (Subject) CIK: 0001344413 (see all company filings)

IRS No.: 770567768 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-82505 | Film No.: 161716719
SIC: 2834 Pharmaceutical Preparations

Mailing Address WALLNERSTRASSE 3/21 VIENNA C4 1010
Business Address WALLNERSTRASSE 3/21 VIENNA C4 1010 (43) 1 22 789-0
LANSDOWNE PARTNERS AUSTRIA GMBH (Filed by) CIK: 0001536071 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C4 | Fiscal Year End: 1231
Type: SC 13D/A